Growth in plant-based foods industry is slowing: Where does it go from here?

by Brooks Johnson, Star TribuneCredit: Unsplash/CC0 Public DomainWhen Willa's Oat Milk launched five years ago, the plant-based market was rapidly expanding, attracting unprecedented attention and

Updated on: April 10,2024

Growth in plant-based foods industry is slowing: Where does it go from here?

by Brooks Johnson, Star TribuneCredit: Unsplash/CC0 Public DomainWhen Willa's Oat Milk launched five years ago, the plant-based market was rapidly expanding, attracting unprecedented attention and

Updated on:April 10,2024

Researchers analyze cancer discrepancies among young Black men in the South

by Vinod Hopson,University of Texas Health Science Center at HoustonRegional Kaposi sarcoma incidence rate trends in non-Hispanic White men aged 20-34. Abbreviation: AAPC, average annual percent

Updated on: January 30,2024

Researchers analyze cancer discrepancies among young Black men in the South

by Vinod Hopson,University of Texas Health Science Center at HoustonRegional Kaposi sarcoma incidence rate trends in non-Hispanic White men aged 20-34. Abbreviation: AAPC, average annual percent

Updated on:January 30,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on: April 30,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on:April 30,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on: May 21,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on:May 21,2024

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Updated on: December 28,2023

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Updated on:December 28,2023

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on: May 23,2024

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on:May 23,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on: April 28,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on:April 28,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on: January 29,2024

Researchers test 'holy grail' tech that could end chemo for some cancer patients

by Caroline Catherman, Orlando SentinelCredit: Pixabay/CC0 Public DomainPeople with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after th

Updated on:January 29,2024

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Updated on: August 27,2024

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

by Leslie Cantu,Medical University of South CarolinaGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI171136A drug that was developed to treat pancr

Updated on:August 27,2024

Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researc

Updated on: August 28,2024

Researchers reveal why vaccines have lower efficacy in patients with multiple myeloma

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researc

Updated on:August 28,2024

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs

Updated on: March 30,2024

A blood test for colon cancer performed well in a study, expanding options for screening

by Carla K. JohnsonThis image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the&nbs

Updated on:March 30,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on: March 30,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on:March 30,2024